Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 20, 2018
RedHill Biopharma to Present at Ladenburg Thalmann 2018 Healthcare Conference
TEL-AVIV, Israel and RALEIGH, N.C., Sept. 20, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty ...
September 20, 2018
Neovasc's Tiara and Reducer to be Featured at TCT 2018 Conference
VANCOUVER , Sept. 20, 2018 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NVCN)(NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve ...
September 20, 2018
Conatus Pharmaceuticals to Host Analyst and Investor Symposium on Portal Hypertension
SAN DIEGO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT), a biotechnology company focused on the development of novel medicines to treat liver ...
September 20, 2018
Arena Pharmaceuticals to Present at Upcoming Investor Conferences
SAN DIEGO, Sept. 20, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that members of its senior management team will participate in the upcoming ...
September 20, 2018
EDAP TMS SA : EDAP announces Installation of First Focal One HIFU device in South Korea
LYON, France, September 20, 2018 -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced the installation of the first Focal One ...
September 20, 2018
Orphazyme to Present at 25th NPUK Annual Family Conference 2018
Copenhagen, September 20, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that Thomas Kirkegaard Jensen, ...
September 20, 2018
VALNEVA Announces Extension of Drawdown Period for its Existing European Investment Bank Loan
Saint Herblain (France), September 20, 2018 - Valneva SE ("Valneva" or "the Company"), a commercial stage biotech company focused on developing innovative lifesaving vaccines, announces ...
September 20, 2018
Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003, Nasal Nalmefene, for Treatment of Opioid Overdose
SANTA MONICA, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, ...
September 19, 2018
Conatus Pharmaceuticals to Participate in Upcoming Investor Conferences
SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT) has accepted invitations to participate in two upcoming investor conferences. At the Oppenheimer ...
September 19, 2018
Soleno Therapeutics to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease
REDWOOD CITY, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
September 19, 2018
Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy
AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM) today announced an agreement with Takeda Pharmaceutical Company Limited (Takeda) for the joint development of ...
September 19, 2018
AIT Therapeutics Presented Nitric Oxide Data at the European Respiratory Society International Congress 2018
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 19, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on ...
September 19, 2018
Achaogen Announces Multiple Plazomicin Presentations at IDWeek 2018
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company discovering, developing, and commercializing innovative antibacterials addressing multi-drug resistant ...
September 19, 2018
Zosano Pharma Completes Manufacture of M207 Registration Batches
FREMONT, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company focused on providing rapid systemic administration ...
September 19, 2018
Neovasc Announces 100th Patient to Receive Reducer Therapy in Germany
VANCOUVER, Sept. 19, 2018 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NVCN) (NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve ...
September 19, 2018
Transgene Presents 2018 Half-Year Results and Business Update
Transgene (TNG.PA) (Euronext Paris: TNG), Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancers and infectious diseases, announces its ...
September 18, 2018
Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to MOB-015 from Moberg Pharma for the topical treatment of Onychomycosis
MISSISSAUGA,ON, Sept. 18, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (CPH.TO) today  announced it has acquired the exclusive Canadian rights to commercialize, promote, sell and distribute ...
September 18, 2018
BioTime Implements New Leadership Structure; Appoints Brian Culley as Chief Executive Officer
BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that the Board of Directors has implemented a new leadership ...
September 18, 2018
Tyme Appoints Accomplished Healthcare Executive Douglas A. Michels to Board of Directors
NEW YORK, Sept. 18, 2018 (GLOBE NEWSWIRE) --  Tyme Technologies, Inc. (TYME), a clinical-stage biotechnology company developing cancer therapeutics, today announced the appointment of Douglas ...
September 18, 2018
Relmada Therapeutics Provides Enrollment Update in Phase 2 Study of REL-1017 in Patients with Major Depressive Disorder
NEW YORK, Sept. 18, 2018 /PRNewswire/ -- Relmada Therapeutics, Inc. (RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) ...
Page 39 of 138